BROMODEOXYURIDINE-LABELED APOPTOSIS AFTER TREATMENT WITH ANTIMETABOLITES IN 2 MURINE TUMORS AND IN SMALL-INTESTINAL CRYPTS

Citation
Ce. Sarraf et al., BROMODEOXYURIDINE-LABELED APOPTOSIS AFTER TREATMENT WITH ANTIMETABOLITES IN 2 MURINE TUMORS AND IN SMALL-INTESTINAL CRYPTS, British Journal of Cancer, 68(4), 1993, pp. 678-680
Citations number
13
Categorie Soggetti
Oncology
Journal title
ISSN journal
00070920
Volume
68
Issue
4
Year of publication
1993
Pages
678 - 680
Database
ISI
SICI code
0007-0920(1993)68:4<678:BAATWA>2.0.ZU;2-E
Abstract
Antimetabolites are S-phase specific anticancer drugs. Administration of bromodeoxyuridine (BrdUrd) to tumour bearing mice was followed by t reatment with cytosine arabinoside or hydroxyurea. Anti-BrdUrd immunoc ytochemistry visualised susceptible tumour and intestinal crypt cells at electron microscope level, showing unequivocally that cells that we re in S-phase at the time of administration of the drugs subsequently died by apoptosis.